• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宿主和病毒因素决定人肺高效感染 SARS-CoV-2。

Host and viral determinants for efficient SARS-CoV-2 infection of the human lung.

机构信息

State Key Laboratory of Emerging Infectious Diseases, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.

Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.

出版信息

Nat Commun. 2021 Jan 8;12(1):134. doi: 10.1038/s41467-020-20457-w.

DOI:10.1038/s41467-020-20457-w
PMID:33420022
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7794309/
Abstract

Understanding the factors that contribute to efficient SARS-CoV-2 infection of human cells may provide insights on SARS-CoV-2 transmissibility and pathogenesis, and reveal targets of intervention. Here, we analyze host and viral determinants essential for efficient SARS-CoV-2 infection in both human lung epithelial cells and ex vivo human lung tissues. We identify heparan sulfate as an important attachment factor for SARS-CoV-2 infection. Next, we show that sialic acids present on ACE2 prevent efficient spike/ACE2-interaction. While SARS-CoV infection is substantially limited by the sialic acid-mediated restriction in both human lung epithelial cells and ex vivo human lung tissues, infection by SARS-CoV-2 is limited to a lesser extent. We further demonstrate that the furin-like cleavage site in SARS-CoV-2 spike is required for efficient virus replication in human lung but not intestinal tissues. These findings provide insights on the efficient SARS-CoV-2 infection of human lungs.

摘要

了解导致 SARS-CoV-2 有效感染人体细胞的因素,可能有助于我们深入了解 SARS-CoV-2 的传染性和发病机制,并揭示干预靶点。在这里,我们分析了宿主和病毒决定因素,这些因素对于 SARS-CoV-2 在人肺上皮细胞和离体人肺组织中的有效感染是必不可少的。我们确定肝素硫酸盐是 SARS-CoV-2 感染的重要附着因子。接下来,我们表明,存在于 ACE2 上的唾液酸会阻碍刺突/ACE2 相互作用的效率。虽然 SARS-CoV 在人肺上皮细胞和离体人肺组织中的感染受到唾液酸介导的限制,但 SARS-CoV-2 的感染受到的限制程度较小。我们进一步证明,SARS-CoV-2 刺突中的类弗林蛋白酶切割位点对于病毒在人肺组织中的有效复制是必需的,但不是在肠道组织中。这些发现为 SARS-CoV-2 有效感染人肺提供了见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0883/7794309/66821f0abee9/41467_2020_20457_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0883/7794309/8ba7ed151a99/41467_2020_20457_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0883/7794309/6aa3cd18fac2/41467_2020_20457_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0883/7794309/a5c8b1ee10e3/41467_2020_20457_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0883/7794309/2d81b56f967b/41467_2020_20457_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0883/7794309/11f888889f64/41467_2020_20457_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0883/7794309/385711642cba/41467_2020_20457_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0883/7794309/66821f0abee9/41467_2020_20457_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0883/7794309/8ba7ed151a99/41467_2020_20457_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0883/7794309/6aa3cd18fac2/41467_2020_20457_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0883/7794309/a5c8b1ee10e3/41467_2020_20457_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0883/7794309/2d81b56f967b/41467_2020_20457_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0883/7794309/11f888889f64/41467_2020_20457_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0883/7794309/385711642cba/41467_2020_20457_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0883/7794309/66821f0abee9/41467_2020_20457_Fig7_HTML.jpg

相似文献

1
Host and viral determinants for efficient SARS-CoV-2 infection of the human lung.宿主和病毒因素决定人肺高效感染 SARS-CoV-2。
Nat Commun. 2021 Jan 8;12(1):134. doi: 10.1038/s41467-020-20457-w.
2
Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve to Higher Infectivity through More Efficient Binding to Heparan Sulfate and Reduced S1/S2 Cleavage.天然和重组 SARS-CoV-2 分离株通过更有效地结合硫酸乙酰肝素和减少 S1/S2 裂解而迅速进化为更高的感染力。
J Virol. 2021 Oct 13;95(21):e0135721. doi: 10.1128/JVI.01357-21. Epub 2021 Aug 18.
3
Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.SARS-CoV-2 感染 ACE2 阴性人呼吸道细胞的系统分析。
Cell Rep. 2021 Jul 13;36(2):109364. doi: 10.1016/j.celrep.2021.109364. Epub 2021 Jun 23.
4
ACE2-Independent Interaction of SARS-CoV-2 Spike Protein with Human Epithelial Cells Is Inhibited by Unfractionated Heparin.SARS-CoV-2 刺突蛋白与人类上皮细胞的非依赖性相互作用被未分级肝素抑制。
Cells. 2021 Jun 7;10(6):1419. doi: 10.3390/cells10061419.
5
Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.弗林蛋白酶和 TMPRSS2 在 SARS-CoV-2 感染中的独特作用。
J Virol. 2022 Apr 27;96(8):e0012822. doi: 10.1128/jvi.00128-22. Epub 2022 Mar 28.
6
The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets.SARS-CoV-2 刺突蛋白中的弗林裂解位点是在雪貂中传播所必需的。
Nat Microbiol. 2021 Jul;6(7):899-909. doi: 10.1038/s41564-021-00908-w. Epub 2021 Apr 27.
7
Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2-ACE2 Receptor Interactions.多学科方法鉴定与人 ACE2 或 SARS-CoV-2 刺突蛋白结合的化合物,作为阻断 SARS-CoV-2-ACE2 受体相互作用的候选药物。
mBio. 2021 Mar 30;12(2):e03681-20. doi: 10.1128/mBio.03681-20.
8
Highly Efficient SARS-CoV-2 Infection of Human Cardiomyocytes: Spike Protein-Mediated Cell Fusion and Its Inhibition.高效感染人类心肌细胞的 SARS-CoV-2:刺突蛋白介导的细胞融合及其抑制。
J Virol. 2021 Nov 23;95(24):e0136821. doi: 10.1128/JVI.01368-21. Epub 2021 Oct 6.
9
Hypoxia reduces cell attachment of SARS-CoV-2 spike protein by modulating the expression of ACE2, neuropilin-1, syndecan-1 and cellular heparan sulfate.缺氧通过调节 ACE2、神经纤毛蛋白 1、 syndecan-1 和细胞肝素硫酸的表达来减少 SARS-CoV-2 刺突蛋白的细胞附着。
Emerg Microbes Infect. 2021 Dec;10(1):1065-1076. doi: 10.1080/22221751.2021.1932607.
10
Sphingosine prevents binding of SARS-CoV-2 spike to its cellular receptor ACE2.鞘氨醇可阻止 SARS-CoV-2 刺突与细胞受体 ACE2 的结合。
J Biol Chem. 2020 Nov 6;295(45):15174-15182. doi: 10.1074/jbc.RA120.015249. Epub 2020 Sep 11.

引用本文的文献

1
An orally available M/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo.一种口服可用的M/TMPRSS2双特异性抑制剂,在体内具有强大的抗冠状病毒功效。
Nat Commun. 2025 Jul 16;16(1):6541. doi: 10.1038/s41467-025-60832-z.
2
Pathogens that infect mammalian cells via sulfonated glycosaminoglycans.通过硫酸化糖胺聚糖感染哺乳动物细胞的病原体。
Front Cell Infect Microbiol. 2025 Jun 10;15:1613923. doi: 10.3389/fcimb.2025.1613923. eCollection 2025.
3
Conserved role of spike S2 domain N-glycosylation across betacoronaviruses.

本文引用的文献

1
Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2.全面表征 SARS-CoV-2 人受体血管紧张素转换酶 2 的 N-和 O-糖基化。
Glycobiology. 2021 May 3;31(4):410-424. doi: 10.1093/glycob/cwaa101.
2
Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor.糖基化 SARS-CoV-2 刺突蛋白与人血管紧张素转换酶 2 受体的病毒-受体相互作用。
Cell Host Microbe. 2020 Oct 7;28(4):586-601.e6. doi: 10.1016/j.chom.2020.08.004. Epub 2020 Aug 24.
3
Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study.
β冠状病毒刺突蛋白S2结构域N-糖基化的保守作用
Npj Viruses. 2025 Jan 25;3(1):4. doi: 10.1038/s44298-024-00085-7.
4
Defining diverse spike-receptor interactions involved in SARS-CoV-2 entry: Mechanisms and therapeutic opportunities.定义参与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)进入的多种刺突蛋白-受体相互作用:机制与治疗机会
Virology. 2025 Jun;607:110507. doi: 10.1016/j.virol.2025.110507. Epub 2025 Mar 21.
5
Efficacy of dispirotripiperazine PDSTP in a golden Syrian hamster model of SARS-CoV-2 infection.双螺环三哌嗪PDSTP在新冠病毒感染的金黄叙利亚仓鼠模型中的疗效
Front Microbiol. 2025 Mar 10;16:1546946. doi: 10.3389/fmicb.2025.1546946. eCollection 2025.
6
Metabolomic characteristics and related pathways in patients with different severity of COVID-19: a systematic review and meta-analysis.不同严重程度新冠病毒病患者的代谢组学特征及相关通路:一项系统综述和荟萃分析
J Glob Health. 2025 Feb 28;15:04056. doi: 10.7189/jogh.15.04056.
7
Anticoagulants utilization in eight hospitals within the Luzhou region from 2019 to 2023.2019年至2023年泸州地区八家医院抗凝剂的使用情况。
PLoS One. 2025 Jan 31;20(1):e0318463. doi: 10.1371/journal.pone.0318463. eCollection 2025.
8
Quantitative Prediction of Protein-Polyelectrolyte Binding Thermodynamics: Adsorption of Heparin-Analog Polysulfates to the SARS-CoV-2 Spike Protein RBD.蛋白质-聚电解质结合热力学的定量预测:肝素类似物多硫酸盐对严重急性呼吸综合征冠状病毒2刺突蛋白受体结合域的吸附
JACS Au. 2025 Jan 6;5(1):204-216. doi: 10.1021/jacsau.4c00886. eCollection 2025 Jan 27.
9
Cellular sialoglycans are differentially required for endosomal and cell-surface entry of SARS-CoV-2 in lung cell lines.细胞唾液酸聚糖对于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)在肺细胞系中的内体和细胞表面进入具有不同需求。
PLoS Pathog. 2024 Dec 3;20(12):e1012365. doi: 10.1371/journal.ppat.1012365. eCollection 2024 Dec.
10
An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo.一种口服可用的Mpro/TMPRSS2双特异性抑制剂,在体内具有强大的抗冠状病毒功效。
Res Sq. 2024 Nov 21:rs.3.rs-5454588. doi: 10.21203/rs.3.rs-5454588/v1.
SARS-CoV-2 和 SARS-CoV 的比较嗜性、复制动力学和细胞损伤特征分析及其对 COVID-19 临床表现、传染性和实验室研究的影响:一项观察性研究。
Lancet Microbe. 2020 May;1(1):e14-e23. doi: 10.1016/S2666-5247(20)30004-5. Epub 2020 Apr 21.
4
Sulfated polysaccharides effectively inhibit SARS-CoV-2 in vitro.硫酸化多糖在体外能有效抑制新型冠状病毒。
Cell Discov. 2020 Jul 24;6(1):50. doi: 10.1038/s41421-020-00192-8. eCollection 2020.
5
Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions.肝素与严重急性呼吸综合征相关冠状病毒 2(SARS-CoV-2)刺突糖蛋白结合相互作用的表征。
Antiviral Res. 2020 Sep;181:104873. doi: 10.1016/j.antiviral.2020.104873. Epub 2020 Jul 10.
6
Retraction Note to: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion.撤回说明:严重急性呼吸综合征冠状病毒2通过其刺突蛋白介导的膜融合感染T淋巴细胞。
Cell Mol Immunol. 2020 Aug;17(8):894. doi: 10.1038/s41423-020-0498-4.
7
Surgical Mask Partition Reduces the Risk of Noncontact Transmission in a Golden Syrian Hamster Model for Coronavirus Disease 2019 (COVID-19).外科口罩分区降低了 2019 冠状病毒病(COVID-19)金黄地鼠模型中非接触传播的风险。
Clin Infect Dis. 2020 Nov 19;71(16):2139-2149. doi: 10.1093/cid/ciaa644.
8
Knowledge synthesis of 100 million biomedical documents augments the deep expression profiling of coronavirus receptors.对 1 亿篇生物医学文献的知识综合增强了冠状病毒受体的深度表达分析。
Elife. 2020 May 28;9:e58040. doi: 10.7554/eLife.58040.
9
Cell entry mechanisms of SARS-CoV-2.SARS-CoV-2 的细胞进入机制。
Proc Natl Acad Sci U S A. 2020 May 26;117(21):11727-11734. doi: 10.1073/pnas.2003138117. Epub 2020 May 6.
10
A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells.SARS-CoV-2 刺突蛋白中的多碱性裂解位点对于感染人肺细胞至关重要。
Mol Cell. 2020 May 21;78(4):779-784.e5. doi: 10.1016/j.molcel.2020.04.022. Epub 2020 May 1.